NeurogesX Inc (NGSX) [Rocket]

In millions, except per share items	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	11.5	8.3	2.0	0.0	0.0	0.0	0.0
Revenue growth	39.2%	312.1%
Cost of goods sold	0.7	0.5	0.0	0.0	0.0	0.0	0.0
Gross profit	10.8	7.7	2.0	0.0	0.0	0.0	0.0
Gross margin	94.0%	93.5%	100.0%
Selling, general and administrative [+]	36.4	36.4	12.4	10.2	7.5	6.1	1.7
General and administrative						6.1	1.7
Research and development	13.6	11.2	11.2	16.1	25.3	20.9	11.8
EBITDA [+]	-38.8	-39.5	-21.5	-26.1	-32.7	-26.8	-13.3
EBITDA growth	-1.7%	83.9%	-17.8%	-20.1%	22.1%	100.8%
EBITDA margin	-337.1%	-477.4%	-1070.0%
Depreciation and amortization	0.4	0.3	0.2	0.2	0.1	0.3	0.2
EBIT [+]	-39.2	-39.8	-21.6	-26.3	-32.8	-27.0	-13.6
EBIT growth	-1.6%	83.9%	-17.6%	-19.8%	21.3%	99.3%
EBIT margin	-340.4%	-481.6%	-1079.2%
Interest expense, net [+]	10.3	5.3	0.2	-0.3	-0.5	-0.2	-0.4
Interest expense	10.4	5.4	0.3	0.8	1.2	0.6	0.0
Interest income	0.1	0.1	0.1	1.1	1.7	0.7	0.4
Other income (expense), net	-0.1	0.6	0.0	-0.1	-4.3	-3.3	0.1
Pre-tax income	-49.5	-44.5	-21.9	-26.0	-36.6	-30.1	-13.1
Income taxes	0.0	0.0	0.0	0.0	-4.6	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	12.6%	0.0%
Net income	-49.5	-44.5	-21.9	-26.0	-36.6	-41.4	-13.1
Net margin	-430.7%	-538.5%	-1090.1%

Basic EPS [+]	($2.15)	($2.51)	($1.24)	($1.49)	($4.06)	($116.20)	$0.00
Growth	-14.1%	101.8%	-16.4%	-63.4%	-96.5%
Diluted EPS [+]	($2.15)	($2.51)	($1.24)	($1.49)	($4.06)	($116.20)	$0.00
Growth	-14.1%	101.8%	-16.4%	-63.4%	-96.5%

Shares outstanding (basic) [+]	23.0	17.8	17.6	17.5	9.0	0.4	0.2
Growth	29.5%	0.9%	0.5%	94.3%	2428.8%	91.4%
Shares outstanding (diluted) [+]	23.0	17.8	17.6	17.5	9.0	0.4	0.2
Growth	29.5%	0.9%	0.5%	94.3%	2428.8%	91.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.